Ken Griffin acquired 235 Thousand Adma Biologics shares worth $1.52 Million. That's 0.00% of their equity portfolio (2437th largest holding). The first Adma Biologics trade was made in Q1 2018. Since then Ken Griffin bought shares nine more times and sold shares on ten occasions. The stake costed the investor $656 Thousand, netting the investor a gain of 131% so far.